Teva offers co-pay program for Gleevec generic
Teva Pharmaceuticals USA has launched a U.S. prescription co-payment assistance program in the U.S. for its imatinib mesylate tablets, a cancer treatment.
CDR
Analysts size up Amazon’s pharmacy opportunity
Pharmacy stands as a sizable growth opportunity for Amazon, and its avenues for market entry include acquisitions, with Rite Aid Corp. and Diplomat Pharmacy Inc. among potential targets, according to Cowen analysts John Blackledge and Charles Rhyee.
Greg Bradley named Foundation Consumer Healthcare CEO
Foundation Consumer Healthcare (FCH) has named Greg Bradley president and chief executive officer. The move comes as Foundation Consumer Healthcare has completed its $675 million acquisition of Plan B One-Step and two value emergency contraceptive brands from Teva Pharmaceutical Industries Ltd.
Loblaw to boost grocery, pharmacy retail analytics access
Loblaw Cos. has tapped Alliance Data Systems Corp. subsidiary Precima to help sharpen its grocery and pharmacy analytics.
Walgreens offers Wine.com order pickup
Walgreens drug stores have become pickup locations for online wine orders via Wine.com. Wine.com Inc.
AmerisourceBergen to buy H.D. Smith
AmerisourceBergen Corp. plans to acquire fellow pharmaceutical distributor H.D. Smith for $815 million in cash. The companies said late Monday that the transaction, pending regulatory review and other closing conditions, is expected to close in early 2018. Springfield, Ill.-based H. D.
PharmaSmart hails updated hypertension guidelines
PharmaSmart International Inc. welcomed new guidelines updating the definition of hypertension and stressing the use of validated devices for measuring blood pressure.
Kaleo to launch Auvi-Q auto-injector for young children
Next year, Kaleo plans to release Auvi-Q 0.1 mg, a version of its epinephrine auto-injector for infants and small children. Kaleo said Monday that the Food and Drug Administration has approved its supplemental New Drug Application (sNDA) for Auvi-Q 0.
Reports: CVS may be near deal to buy Aetna
A deal for CVS Health to acquire Aetna Inc. could happen by the end of the month, published reports say. Citing anonymous sources, The Wall Street Journal reported Monday that CVS was nearing a $66 billion agreement to buy the health insurer, according to reports.
Surgeon General, senator extend kudos to CVS
U.S. Surgeon General Jerome Adams, M.D., and Sen. Sheldon Whitehouse (D., R.I.) hailed CVS Health’s efforts to cut tobacco use in a recent hearing of the Senate Health, Education, Labor and Pensions (HELP) Committee.
Anderson spotlights pharmacy’s public health role
NACDS president and CEO Steve Anderson co-authored an article appearing in Morning Consult that highlights the role of pharmacy in public health.
Kaufmann named Cardinal CEO, succeeding Barrett
Mike Kaufmann has been named chief executive officer of Cardinal Health Inc., effective January 1. The 54-year-old Kaufmann, Cardinal’s chief financial officer, will succeed George Barrett.
Ashworth promoted by WBA
Walgreens Boots Alliance Inc. (WBA) has promoted Richard Ashworth to president of operations at Walgreens, a newly created position.
NACDS: Pharmacy can be major player in opioid crisis
Pharmacy can be key to thwarting opioid abuse, National Association of Chain Drug Stores president and chief executive officer Steve Anderson told a government summit on the opioid crisis.
CVS to offer next-day prescription delivery
CVS Pharmacy will launch next-day prescription delivery nationwide in early 2018. As part of the CVS next-day prescription delivery rollout, same-day delivery will be available in selected cities, with the service beginning in New York next month.
McKesson buys RxCrossroads
McKesson Corp. has agreed to buy RxCrossroads, a provider of tailored services to pharmaceutical and biotechnology manufacturers, from CVS Health. The deal, expected to close early next year, is valued at $735 million, or about $635 million net of the present value of incremental cash tax benefits.